Correlation Between Cingulate Warrants and Shuttle Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Shuttle Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Shuttle Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Shuttle Pharmaceuticals, you can compare the effects of market volatilities on Cingulate Warrants and Shuttle Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Shuttle Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Shuttle Pharmaceuticals.
Diversification Opportunities for Cingulate Warrants and Shuttle Pharmaceuticals
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cingulate and Shuttle is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Shuttle Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shuttle Pharmaceuticals and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Shuttle Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shuttle Pharmaceuticals has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Shuttle Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Shuttle Pharmaceuticals
Assuming the 90 days horizon Cingulate Warrants is expected to generate 22.9 times more return on investment than Shuttle Pharmaceuticals. However, Cingulate Warrants is 22.9 times more volatile than Shuttle Pharmaceuticals. It trades about 0.14 of its potential returns per unit of risk. Shuttle Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest 12.00 in Cingulate Warrants on September 12, 2024 and sell it today you would lose (8.37) from holding Cingulate Warrants or give up 69.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 74.92% |
| Values | Daily Returns |
Cingulate Warrants vs. Shuttle Pharmaceuticals
Performance |
| Timeline |
| Cingulate Warrants |
| Shuttle Pharmaceuticals |
Cingulate Warrants and Shuttle Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate Warrants and Shuttle Pharmaceuticals
The main advantage of trading using opposite Cingulate Warrants and Shuttle Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Shuttle Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shuttle Pharmaceuticals will offset losses from the drop in Shuttle Pharmaceuticals' long position.| Cingulate Warrants vs. Equillium | Cingulate Warrants vs. DiaMedica Therapeutics | Cingulate Warrants vs. Valneva SE ADR | Cingulate Warrants vs. Vivani Medical |
| Shuttle Pharmaceuticals vs. Lifecore Biomedical | Shuttle Pharmaceuticals vs. Catalent | Shuttle Pharmaceuticals vs. Tilray Inc | Shuttle Pharmaceuticals vs. Organogenesis Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |